Clinical features | ICGC, n = 231 | GSE14520, n = 242 | ||||
---|---|---|---|---|---|---|
High risk | Low risk | P | High risk | Low risk | P | |
Survival status | 0.04 | 0.04 | ||||
Survived | 43 | 146 | 12 | 134 | ||
Died | 16 | 26 | 16 | 80 | ||
Age | 0.63 | 0.17 | ||||
≥ 60 years | 49 | 138 | 3 | 47 | ||
< 60 years | 10 | 34 | 25 | 167 | ||
Sex | 0.84 | 0.12 | ||||
Male | 44 | 126 | 27 | 184 | ||
Female | 15 | 46 | 1 | 30 | ||
Stage | < 0.001 | 0.08 | ||||
I–II | 25 | 116 | 18 | 156 | ||
III–IV | 34 | 56 | 10 | 41 | ||
x | 0 | 0 | 0 | 17 | ||
Histological grade | < 0.01 | |||||
G1–2 | 30 | 128 | ||||
G3–4 | 21 | 33 | ||||
Gx | 8 | 11 | ||||
Cirrhosis status | 0.37 | |||||
No cirrhosis | 1 | 18 | ||||
Cirrhosis | 27 | 196 | ||||
Recurrence status | 0.19 | |||||
No recurrence | 9 | 97 | ||||
Recurrence | 19 | 117 | ||||
Hepatitis status | 0.23 | |||||
Hepatitis B | 27 | 191 | ||||
No hepatitis | 1 | 23 |